Clinical Trial Update: Effects of TD-4208 on FEV1 in Subjects With Chronic Obstructive Pulmonary Disease (COPD) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating TD-4208 effects on FEV1 in subjects with chronic obstructive pulmonary disease (COPD); results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• TD-4208 (TD-4208)

Snippet

Sponsor: Mylan Inc. | Conditions: Chronic Obstructive Pulmonary Disease, COPD | Phase 2 | Status: COMPLETED | Results posted: 2019-11-14